company background image
3320

China Resources Pharmaceutical Group SEHK:3320 Stock Report

Last Price

HK$4.73

Market Cap

HK$28.6b

7D

5.8%

1Y

16.8%

Updated

17 Aug, 2022

Data

Company Financials +
3320 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance3/6
Financial Health4/6
Dividends3/6

3320 Stock Overview

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong.

China Resources Pharmaceutical Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China Resources Pharmaceutical Group
Historical stock prices
Current Share PriceHK$4.73
52 Week HighHK$5.58
52 Week LowHK$3.18
Beta0.38
1 Month Change-4.44%
3 Month Change5.11%
1 Year Change16.79%
3 Year Change-41.89%
5 Year Change-50.11%
Change since IPO-47.50%

Recent News & Updates

May 29
China Resources Pharmaceutical Group (HKG:3320) Has Announced That It Will Be Increasing Its Dividend To HK$0.15

China Resources Pharmaceutical Group (HKG:3320) Has Announced That It Will Be Increasing Its Dividend To HK$0.15

China Resources Pharmaceutical Group Limited's ( HKG:3320 ) dividend will be increasing to HK$0.15 on 25th of July...

Shareholder Returns

3320HK PharmaceuticalsHK Market
7D5.8%-2.8%-0.5%
1Y16.8%-35.7%-20.6%

Return vs Industry: 3320 exceeded the Hong Kong Pharmaceuticals industry which returned -35.7% over the past year.

Return vs Market: 3320 exceeded the Hong Kong Market which returned -20.6% over the past year.

Price Volatility

Is 3320's price volatile compared to industry and market?
3320 volatility
3320 Average Weekly Movement5.9%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.5%
10% most volatile stocks in HK Market12.6%
10% least volatile stocks in HK Market3.2%

Stable Share Price: 3320 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 3320's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200765,000Xiaosong Baihttps://www.crpharm.com

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. It offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. The company also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies.

China Resources Pharmaceutical Group Limited Fundamentals Summary

How do China Resources Pharmaceutical Group's earnings and revenue compare to its market cap?
3320 fundamental statistics
Market CapHK$28.65b
Earnings (TTM)HK$3.77b
Revenue (TTM)HK$236.81b

7.9x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
3320 income statement (TTM)
RevenueHK$236.81b
Cost of RevenueHK$201.43b
Gross ProfitHK$35.38b
Other ExpensesHK$31.61b
EarningsHK$3.77b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 25, 2022

Earnings per share (EPS)0.60
Gross Margin14.94%
Net Profit Margin1.59%
Debt/Equity Ratio69.9%

How did 3320 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

25%

Payout Ratio